section name header

Footnotes

a Final concentration after mixing.

b Tested in sodium chloride 0.9%.

c Tested in both dextrose 5% and sodium chloride 0.9%.

d Test performed using the Cubicin formulation.

e Formulation not specified.

f Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

g Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

h Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.

i Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

j Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.